AASLD: New HCV Drug Promising, Cuts Out Interferon (CME/CE)
(MedPage Today) — SAN FRANCISCO -– Treatment with an investigational hepatitis C drug allowed investigators to dispense with an old stand-by — pegylated interferon-alpha.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com